143 related articles for article (PubMed ID: 10975896)
1. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles.
Anderson SA; Rader RK; Westlin WF; Null C; Jackson D; Lanza GM; Wickline SA; Kotyk JJ
Magn Reson Med; 2000 Sep; 44(3):433-9. PubMed ID: 10975896
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging and therapy directed at the neovasculature in pathologies. How imaging can be incorporated into vascular-targeted delivery systems to generate active therapeutic agents.
Guccione S; Li KC; Bednarski MD
IEEE Eng Med Biol Mag; 2004; 23(5):50-6. PubMed ID: 15565799
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.
Winter PM; Morawski AM; Caruthers SD; Fuhrhop RW; Zhang H; Williams TA; Allen JS; Lacy EK; Robertson JD; Lanza GM; Wickline SA
Circulation; 2003 Nov; 108(18):2270-4. PubMed ID: 14557370
[TBL] [Abstract][Full Text] [Related]
6. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model.
Yoon KC; Ahn KY; Lee JH; Chun BJ; Park SW; Seo MS; Park YG; Kim KK
Gene Ther; 2005 Apr; 12(7):617-24. PubMed ID: 15703766
[TBL] [Abstract][Full Text] [Related]
7. High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model.
Lijowski M; Caruthers S; Hu G; Zhang H; Scott MJ; Williams T; Erpelding T; Schmieder AH; Kiefer G; Gulyas G; Athey PS; Gaffney PJ; Wickline SA; Lanza GM
Invest Radiol; 2009 Jan; 44(1):15-22. PubMed ID: 18836386
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
Schmieder AH; Caruthers SD; Zhang H; Williams TA; Robertson JD; Wickline SA; Lanza GM
FASEB J; 2008 Dec; 22(12):4179-89. PubMed ID: 18697838
[TBL] [Abstract][Full Text] [Related]
9. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
Schmieder AH; Winter PM; Caruthers SD; Harris TD; Williams TA; Allen JS; Lacy EK; Zhang H; Scott MJ; Hu G; Robertson JD; Wickline SA; Lanza GM
Magn Reson Med; 2005 Mar; 53(3):621-7. PubMed ID: 15723405
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of corneal neovascularization by alpha(v)-integrin antagonists in the rat.
Klotz O; Park JK; Pleyer U; Hartmann C; Baatz H
Graefes Arch Clin Exp Ophthalmol; 2000 Jan; 238(1):88-93. PubMed ID: 10664059
[TBL] [Abstract][Full Text] [Related]
11. Definition of two angiogenic pathways by distinct alpha v integrins.
Friedlander M; Brooks PC; Shaffer RW; Kincaid CM; Varner JA; Cheresh DA
Science; 1995 Dec; 270(5241):1500-2. PubMed ID: 7491498
[TBL] [Abstract][Full Text] [Related]
12. Studying Angiogenesis in the Rabbit Corneal Pocket Assay.
Morbidelli L; Ciccone V; Ziche M
Methods Mol Biol; 2021; 2206():89-101. PubMed ID: 32754813
[TBL] [Abstract][Full Text] [Related]
13. Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy.
Waters EA; Chen J; Yang X; Zhang H; Neumann R; Santeford A; Arbeit J; Lanza GM; Wickline SA
Magn Reson Med; 2008 Nov; 60(5):1232-6. PubMed ID: 18956417
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound and magnetic resonance molecular imaging of atherosclerotic neovasculature with perfluorocarbon magnetic nanocapsules targeted against vascular endothelial growth factor receptor 2 in rats.
Chen H; Chen L; Liang R; Wei J
Mol Med Rep; 2017 Nov; 16(5):5986-5996. PubMed ID: 28849045
[TBL] [Abstract][Full Text] [Related]
16. Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS.
Waters EA; Chen J; Allen JS; Zhang H; Lanza GM; Wickline SA
J Cardiovasc Magn Reson; 2008 Sep; 10(1):43. PubMed ID: 18817557
[TBL] [Abstract][Full Text] [Related]
17. Preparation of polymer-based magnetic resonance imaging contrast agent to visualize therapeutic angiogenesis.
Jo J; Lin X; Nakahara T; Aoki I; Saga T; Tabata Y
Tissue Eng Part A; 2013 Jan; 19(1-2):30-9. PubMed ID: 22838390
[TBL] [Abstract][Full Text] [Related]
18. Determinants of myocardial response in CMR perfusion imaging using Gd-BOPTA (Multihance).
Gebker R; Paetsch I; Neuss M; Schnackenburg B; Bornstedt A; Jahnke C; Gomaa O; Fleck E; Nagel E
J Cardiovasc Magn Reson; 2005; 7(3):565-72. PubMed ID: 15959969
[TBL] [Abstract][Full Text] [Related]
19. Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel.
Yang CF; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Tabata Y; Ikada Y; Ogura Y
Ophthalmic Res; 2000; 32(1):19-24. PubMed ID: 10657751
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.
Sipkins DA; Cheresh DA; Kazemi MR; Nevin LM; Bednarski MD; Li KC
Nat Med; 1998 May; 4(5):623-6. PubMed ID: 9585240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
